| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis
|
Fujiwara, Naoto
|
|
|
2 |
7 |
p. 836-850.e10
|
article
|
| 2 |
A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes
|
Schneider, Carolin V.
|
|
|
2 |
7 |
p. 851-863.e3
|
article
|
| 3 |
Finding a sweet spot for leptin
|
Brown, Rebecca J.
|
|
|
2 |
7 |
p. 794-796
|
article
|
| 4 |
Getting better mileage with logically primed CARs
|
Chen, Laurence C.
|
|
|
2 |
7 |
p. 785-787
|
article
|
| 5 |
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
|
Kazierad, David J.
|
|
|
2 |
7 |
p. 800-813.e3
|
article
|
| 6 |
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease
|
Matei, Diana E.
|
|
|
2 |
7 |
p. 864-883.e9
|
article
|
| 7 |
Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
|
Akinci, Baris
|
|
|
2 |
7 |
p. 814-835.e6
|
article
|
| 8 |
More than meets the eye: Using AI to identify reduced heart function by electrocardiograms
|
Muse, Evan D.
|
|
|
2 |
7 |
p. 791-793
|
article
|
| 9 |
PLSec: A novel, liquid biomarker for HCC risk
|
Franses, Joseph W.
|
|
|
2 |
7 |
p. 788-790
|
article
|
| 10 |
Smartwatch biomarkers and the path to clinical use
|
Picard, Rosalind W.
|
|
|
2 |
7 |
p. 797-799
|
article
|
Journal description